Financial News

Halozyme Therapeutic (NQ: HALO )

47.53 USD +0.03 (+0.07%)

Streaming Delayed Price Updated: 10:49 AM EST, Jan 22, 2021 Add to My Watchlist

Price and Volume

Volume	99,859
Open	46.78
Bid (Size)	47.45 (2)
Ask (Size)	47.60 (2)
Prev. Close	47.50
Today's Range	46.68 - 47.85
52wk Range	12.71 - 49.02
Shares Outstanding	143,965,620
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASPRO® (Daratumumab And Hyaluronidase-fihj) As Treatment For Newly Diagnosed Patients With Light Chain (AL) Amyloidosis

January 15, 2021

- DARZALEX FASPRO® Utilizing ENHANZE® Represents First and Only Approved Treatment for Patients with Newly Diagnosed AL Amyloidosis -

Halozyme Provides 2021 Financial Guidance Highlighted By Strong Revenue And EPS Growth

January 11, 2021

- 2021 Revenue Guidance of $375 to $395 Million Representing 40%-45% Growth over Expected 2020 Revenue -

Performance

YTD	+12.08%	+12.08%
1 Month	+10.01%	+10.01%
3 Month	+52.89%	+52.89%
6 Month	+74.63%	+74.63%
1 Year	+143.15%	+143.15%

More News

Halozyme To Present Virtually At The 39th Annual J.P. Morgan Healthcare Conference

January 04, 2021

Halozyme Announces Roche Receives European Commission Approval For Phesgo® (Fixed-Dose Combination Of Perjeta® And Herceptin® For Subcutaneous Injection) Utilizing Halozyme's ENHANZE® Technology For T

December 23, 2020

First Week of September 17th Options Trading For Halozyme Therapeutics

January 15, 2021

Nintendo Executives Laughed When Microsoft Tried To Acquire Gaming Company: Report

January 07, 2021

Dow Jones Weakens Following JPMorgan Earnings; Nasdaq Falls Less, But Some Growth Stocks Power Higher

January 15, 2021

Strange: Bullish HALO Analysts Actually See -16.88% Downside

December 21, 2020

Why These 3 Health Care Stocks Are Moving Today

December 17, 2020

The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping

January 21, 2021

The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study

January 20, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Halozyme Therapeutic (NQ: HALO )

Price and Volume

Top News

Performance

More News

Popular Pages